Publication
Tumor-Intrinsic Blood and Imaging Correlatives in Advanced Prostate Cancer Treated with Combination Radiopharmaceutical Therapy and Immunotherapy.
Sofie H Tolmeijer, Edmond M Kwan, Andrei Gafita, Anis A Hamid, Shivakumar Keerthikumar, Narjess Ayati, Mathias Bressel, Anthony M Joshua, Louise Emmett, Megan Crumbaker, Sarah W S Ng, Gráinne Donnellan, Angelyn Anton, Lavinia Spain, Lisa G Horvath, Joanna Chan, James P Buteau, Arielle van Mourik, Nattakorn Dhiantravan, Andrisha-Jade Inderjeeth, Martin Sjöström, Aishwarya Subramanian, Santosh Gupta, Narelle Williams, Anupama Pasam, David Olmos, Nicole M Haynes, Paul J Neeson, David Quigley, David L Goode, Rodney J Hicks, Michael S Hofman, Alexander W Wyatt, Shahneen Sandhu
- Source
- PubMed
- Retrieved
- Sep 12, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260912-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
The PRINCE trial showed the clinical activity for 177Lu-PSMA-617 in combination with pembrolizumab for metastatic castration-resistant prostate cancer. To refine patient selection and improve response monitoring strategies to this combination, we investigated candidate tumor-intrinsic biomarkers of…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Prostate Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available